
FDA's Priority Voucher Program Faces Criticism Amid Drug Review Controversies
A new FDA voucher program intended to expedite drug reviews is being used by political officials, including the White House, to influence which medicines are fast-tracked, raising concerns among career scientists about political interference in the drug approval process.
